178 related articles for article (PubMed ID: 14757843)
1. MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides.
Bartel F; Harris LC; Würl P; Taubert H
Mol Cancer Res; 2004 Jan; 2(1):29-35. PubMed ID: 14757843
[TBL] [Abstract][Full Text] [Related]
2. The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells.
Traidej M; Chen L; Yu D; Agrawal S; Chen J
Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):17-27. PubMed ID: 10726657
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines.
Weng MW; Lai JC; Hsu CP; Yu KY; Chen CY; Lin TS; Lai WW; Lee H; Ko JL
Environ Mol Mutagen; 2005 Jul; 46(1):1-11. PubMed ID: 15714438
[TBL] [Abstract][Full Text] [Related]
4. Alternative and aberrant splicing of MDM2 mRNA in human cancer.
Bartel F; Taubert H; Harris LC
Cancer Cell; 2002 Jul; 2(1):9-15. PubMed ID: 12150820
[TBL] [Abstract][Full Text] [Related]
5. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Yu D; Agrawal S; Zhang R
Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
[TBL] [Abstract][Full Text] [Related]
6. Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms.
Zhang R; Wang H; Agrawal S
Curr Cancer Drug Targets; 2005 Feb; 5(1):43-9. PubMed ID: 15720188
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
[TBL] [Abstract][Full Text] [Related]
8. Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation.
Mu Z; Hachem P; Agrawal S; Pollack A
Prostate; 2004 Aug; 60(3):187-96. PubMed ID: 15176048
[TBL] [Abstract][Full Text] [Related]
9. Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific.
Bartel F; Pinkert D; Fiedler W; Kappler M; Würl P; Schmidt H; Taubert H
Int J Oncol; 2004 Jan; 24(1):143-51. PubMed ID: 14654951
[TBL] [Abstract][Full Text] [Related]
10. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.
Matsumoto R; Tada M; Nozaki M; Zhang CL; Sawamura Y; Abe H
Cancer Res; 1998 Feb; 58(4):609-13. PubMed ID: 9485008
[TBL] [Abstract][Full Text] [Related]
11. Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.
Würl P; Bartel F; Meye A; Kappler M; Bache M; Schmidt H; Schönfelder M; Taubert H
Int J Oncol; 2002 May; 20(5):1087-93. PubMed ID: 11956608
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization by antisense oligonucleotides targeting MDM2.
Bianco R; Ciardiello F; Tortora G
Curr Cancer Drug Targets; 2005 Feb; 5(1):51-6. PubMed ID: 15720189
[TBL] [Abstract][Full Text] [Related]
13. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
14. Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.
Liang H; Atkins H; Abdel-Fattah R; Jones SN; Lunec J
Gene; 2004 Sep; 338(2):217-23. PubMed ID: 15315825
[TBL] [Abstract][Full Text] [Related]
15. Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides.
Geiger T; Hüsken D; Weiler J; Natt F; Woods-Cook KA; Hall J; Fabbro D
Anticancer Drug Des; 2000 Dec; 15(6):423-30. PubMed ID: 11716435
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Oliver P; Zhang Z; Agrawal S; Zhang R
Ann N Y Acad Sci; 2003 Dec; 1002():217-35. PubMed ID: 14751837
[TBL] [Abstract][Full Text] [Related]
17. Identification and expression of a novel MDM4 splice variant in human glioma.
Wang X; Sheng P; Guo X; Wang J; Hou L; Hu G; Luo C; Dong Y; Lu Y
Brain Res; 2013 Nov; 1537():260-6. PubMed ID: 23994448
[TBL] [Abstract][Full Text] [Related]
18. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
19. Loss of Pnn expression attenuates expression levels of SR family splicing factors and modulates alternative pre-mRNA splicing in vivo.
Chiu Y; Ouyang P
Biochem Biophys Res Commun; 2006 Mar; 341(2):663-71. PubMed ID: 16430868
[TBL] [Abstract][Full Text] [Related]
20. Identification of two novel mRNA splice variants of bax.
Thomas AL; Price C; Martin SG; Carmichael J; Murray JC
Cell Death Differ; 1999 Feb; 6(2):97-8. PubMed ID: 10200554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
